山东京卫制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
67
NMPA:67
Drug Approvals
Quetiapine Fumarate Tablets
- Product Name
- 富马酸喹硫平片
- Approval Number
- 国药准字H20258051
- Approval Date
- Apr 2, 2025
NMPA
Quetiapine Fumarate Tablets
- Product Name
- 富马酸喹硫平片
- Approval Number
- 国药准字H20258052
- Approval Date
- Apr 2, 2025
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20253376
- Approval Date
- Feb 11, 2025
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20253212
- Approval Date
- Jan 14, 2025
NMPA
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20249500
- Approval Date
- Dec 1, 2024
NMPA
Tandospirone Citrate Tablets
- Product Name
- 枸橼酸坦度螺酮片
- Approval Number
- 国药准字H20249656
- Approval Date
- Dec 1, 2024
NMPA
Tandospirone Citrate Tablets
- Product Name
- 枸橼酸坦度螺酮片
- Approval Number
- 国药准字H20249657
- Approval Date
- Dec 1, 2024
NMPA
Ambroxol Hydrochloride Drops
- Product Name
- 盐酸氨溴索滴剂
- Approval Number
- 国药准字H20249241
- Approval Date
- Nov 5, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found